STUART LERNER: Open Payments
NPI 1881647782 · KAILUA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,706 in 102 payments from 18 companies in 2025. Trend: 2023 $1,421 · 2024 $3,425 · 2025 $4,706
Food & beverage: $4,695Education: $11
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $853 |
| ABBVIE INC. | 19 | $759 |
| Boston Scientific Corporation | 5 | $609 |
| Janssen Biotech, Inc. | 4 | $441 |
| Vanda Pharmaceuticals Inc. | 10 | $299 |
| Lilly USA, LLC | 3 | $255 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $208 |
| Amgen Inc. | 4 | $200 |
| GlaxoSmithKline, LLC. | 15 | $181 |
| GENZYME CORPORATION | 6 | $177 |
Products named: VRAYLAR, General - Pain Management, TREMFYA, AIRSUPRA, DUPIXENT, BREZTRI, FANAPT, Kerendia.
Industry payments across HI — which companies pay providers there.
